Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis

被引:0
|
作者
Luca, M
Huang, SY
Gershenwald, JE
Singh, RK
Reich, R
BarEli, M
机构
[1] UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT CELL BIOL,HOUSTON,TX 77030
[2] HEBREW UNIV JERUSALEM,DEPT PHARMACOL,JERUSALEM,ISRAEL
来源
AMERICAN JOURNAL OF PATHOLOGY | 1997年 / 151卷 / 04期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Expression of interleukin-8 (IL-8) by human melanoma tells correlates with their metastatic potential. Moreover, UV-B irradiation of primary cutaneous melanoma cells induces IL-8 mRNA and protein production and increases both tumor growth and metastasis in nude mice. Although IL-8 has been shown to be an angiogenic factor, the biological consequences of increased IL-8 production by melanoma cells and the role of IL-8 in the metastatic process remains unclear. The purpose of this study was to determine the role of IL-8 in tumor growth and metastasis of human melanoma cells. Nonmetastatic SB-2 melanoma cells with negligible levels of IL-8 were transfected with IL-8 cDNA and subsequently analyzed for changes in their tumorigenic and metastatic potential. Enforced expression of IL-8 rendered the melanoma cells highly tumorigenic and increased their metastatic potential as compared with parental and control transfected cells. The IL-8-transfected cells displayed up-regulation in M-r 72,000 collagenase type IV (MMP-2) mRNA and collagenase activity and increased invasiveness through Matrigel-coated filters. Moreover, when the MMP-2 promoter was linked upstream of the chloramphenicol acetyltransferase (CAT) reporter gene, CAT activity was up-regulated in IL-8 but not in control transfected cells, suggesting that IL-8 is involved in MMP-2 gene transcription. Activation of type IV collagenase by IL-8 can enhance the invasion of host stroma by the tumor cells and increase angiogenesis and, hence, metastasis.
引用
收藏
页码:1105 / 1113
页数:9
相关论文
共 50 条
  • [41] Tissue Inhibitors of Metalloproteinase 2 Up-regulates Beta-catenin Activity in Melanoma Cells
    Xia, Y.
    Wu, S.
    Sun, J.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [42] Metalloproteinase-8 gene delivery up-regulates MMP-2, MMP-3 and induces cell proliferation in experimental liver cirrhosis.
    Armendariz-Borunda, J
    Siller-Lopez, F
    Garcia, J
    Sandoval, A
    Salgado, S
    Salazar, A
    Aguilar-Cordova, E
    HEPATOLOGY, 2003, 38 (04) : 585A - 585A
  • [43] EXPRESSION OF INTERLEUKIN-8 CORRELATES WITH THE METASTATIC POTENTIAL OF HUMAN-MELANOMA CELLS IN NUDE-MICE
    SINGH, RK
    GUTMAN, M
    RADINSKY, R
    BUCANA, CD
    FIDLER, IJ
    CANCER RESEARCH, 1994, 54 (12) : 3242 - 3247
  • [44] WISP-1 increases MMP-2 expression and cell motility in human chondrosarcoma cells
    Hou, Chun-Han
    Chiang, Yi-Chun
    Fong, Yi-Chin
    Tang, Chih-Hsin
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (11) : 1286 - 1295
  • [45] Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: Potential inhibition of angiogenesis
    Huang, SY
    Xie, KP
    Bucana, CD
    Ullrich, SE
    BarEli, M
    CLINICAL CANCER RESEARCH, 1996, 2 (12) : 1969 - 1979
  • [46] HUMAN-MELANOMA CELLS PRODUCE INTERLEUKIN-8 WHICH FUNCTIONS AS AN AUTOCRINE GROWTH-FACTOR
    FORSTER, E
    KIRNBAUER, R
    URBANSKI, A
    KOCK, A
    LUGER, TA
    SCHWARZ, T
    CLINICAL RESEARCH, 1991, 39 (02): : A517 - A517
  • [47] WISP-1 increases MMP-2 expression and cell motility in human chondrosarcoma cells
    Chiang, Yi-Chun
    Tang, Chih-Hsin
    Tan, Tzu-Wei
    CANCER RESEARCH, 2011, 71
  • [48] Fibroblast growth factor-2 up-regulates telomerase activity in endothelial cells
    Kurz, DJ
    Decary, S
    Hong, Y
    Erusalimsky, JD
    EUROPEAN HEART JOURNAL, 2001, 22 : 136 - 136
  • [49] IL-2 up-regulates the expression of IL-24 resulting in growth suppression in melanoma
    Jen, Emily
    Poindexter, Nancy
    Grimm, Elizabeth
    CANCER RESEARCH, 2009, 69
  • [50] Interleukin-12 up-regulates fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity
    Zhou, ZC
    Lafleur, EA
    Koshkina, NV
    Worth, LL
    Lester, MS
    Kleinerman, ES
    MOLECULAR CANCER RESEARCH, 2005, 3 (12) : 685 - 691